(Q42983436)

12 November 2017

title

Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection (English)

1 reference

12 November 2017

1 reference

3

1 reference

12 November 2017

Yee LJ

1

1 reference

12 November 2017

Knapp S

2

1 reference

12 November 2017

Hennig BJ

4

1 reference

12 November 2017

Frodsham AJ

5

1 reference

12 November 2017

Wright M

6

1 reference

12 November 2017

Thomas HC

7

1 reference

12 November 2017

Hill AV

8

1 reference

12 November 2017

Thursz MR

9

1 reference

12 November 2017

language of work or name

1 reference

1 May 2004

1 reference

12 November 2017

1 reference

12 November 2017

volume

5

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

183-187

1 reference

Nitric oxide and infectious diseases

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Identification of nitric oxide synthase as a protective locus against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Altered immune responses in mice lacking inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Haplotypic relationship between SNP and microsatellite markers at the NOS2A locus in two populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Compartmentalised inducible nitric-oxide synthase activity in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

inferred from DOI database lookup

7 January 2021

based on heuristic

Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364054

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GENE.6364054

1 reference

12 November 2017

1 reference